Skip to main content
. 2024 Oct 27;150(25):1990–2003. doi: 10.1161/CIRCULATIONAHA.124.072370

Figure 1.

Figure 1.

Risk of acute kidney injury and renal replacement therapy in both study arms. A, Unadjusted cumulative risk of acute kidney injury (AKI) according to RIFLE criteria (Risk, Injury, Failure, Loss, and End-stage kidney disease). B, Unadjusted cumulative incidence of renal replacement therapy until 30 days after randomization (Gray test adjusting for competing risk of death). mAFP indicates microaxial flow pump.